Analytical Data
-
Gene name
CXCL3
- Application
-
Alternative Names
CXCL3；GRO3；GROG；SCYB3;C-X-C motif chemokine 3
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P19876
-
Expression Region
35-107aa
-
AA Sequence
ASVVTELRCQCLQTLQGIHLKNIQSVNVRSPGPHCAQTEVIATLKNGKKA CLNPASPMVQKIIEKILNKGSTN
-
Molecular Weight
8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CXCL3, also known as chemokine (C-X-C motif) ligand 3, is a member of the CXC chemokine family, playing crucial roles in immune response and inflammation. It is primarily involved in the recruitment and activation of neutrophils at sites of injury or infection. Given its significant functions in various physiological and pathological processes, including tissue repair, cancer metastasis, and autoimmune diseases, researchers are increasingly focusing on the therapeutic potential of CXCL3 and its recombinant protein. The study of CXCL3 recombinant protein allows for the investigation of its molecular mechanisms, interactions with receptors such as CXCR2, and its implications in both innate and adaptive immunity. Moreover, understanding the structure and function of CXCL3 at a detailed level can lead to the development of targeted therapies that modulate its activity. Current research in this field aims to optimize the production of CXCL3 recombinant protein for experimental and clinical applications, explore its role in modulating immune responses, and assess its potential as a biomarker for various diseases. The advancement of biotechnological methods enhances the scalability and efficacy of CXCL3 recombinant protein production, paving the way for innovative treatments in immunology and oncology.
